Related references
Note: Only part of the references are listed.Metformin, rosiglitazone, or both for obese women with polycystic ovary syndrome?
Sushila Arya et al.
FERTILITY AND STERILITY (2020)
Fructose levels are elevated in women with polycystic ovary syndrome with obesity and hyperinsulinemia
Bei Shi et al.
HUMAN REPRODUCTION (2020)
The effect of synbiotics supplementation on anthropometric indicators and lipid profiles in women with polycystic ovary syndrome: a randomized controlled trial
Elham Karimi et al.
LIPIDS IN HEALTH AND DISEASE (2020)
The effects of curcumin supplementation on oxidative stress, Sirtuin-1 and peroxisome proliferator activated receptor γ coactivator 1α gene expression in polycystic ovarian syndrome (PCOS) patients: A randomized placebo-controlled clinical trial
Javad Heshmati et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
The association between fat mass and the risk of breast cancer: A systematic review and meta-analysis
Nazli Namazi et al.
CLINICAL NUTRITION (2019)
A benefit-harm analysis of adding basal insulin vs. sulfonylurea to metformin to manage type II diabetes mellitus in people with multiple chronic conditions
Wendy L. Bennett et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2019)
Changes in whole metabolites after exenatide treatment in overweight/obese polycystic ovary syndrome patients
Liang Tang et al.
CLINICAL ENDOCRINOLOGY (2019)
Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS)
Yan Li et al.
LIFE SCIENCES (2019)
Management of overweight and obesity in primary care-A systematic overview of international evidence-based guidelines
Thomas Semlitsch et al.
OBESITY REVIEWS (2019)
Randomised controlled trial to study the efficacy of exercise with and without metformin on women with polycystic ovary syndrome
Nisha Tiwari et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2019)
Effect of Metformin on Microvascular Endothelial Function in Polycystic Ovary Syndrome
Behnam Heidari et al.
MAYO CLINIC PROCEEDINGS (2019)
The Effects of Probiotics or Synbiotics Supplementation in Women with Polycystic Ovarian Syndrome: a Systematic Review and Meta-Analysis of Randomized Clinical Trials
Javad Heshmati et al.
PROBIOTICS AND ANTIMICROBIAL PROTEINS (2019)
MiRNAs Regulating Insulin Sensitivity Are Dysregulated in Polycystic Ovary Syndrome (PCOS) Ovaries and Are Associated With Markers of Inflammation and Insulin Sensitivity
Francesca Cirillo et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Impact of weight loss on plasma ghrelin level, clinical, and metabolic features of obese women with or without polycystic ovary syndrome
Nearmeen M. Rashad et al.
MIDDLE EAST FERTILITY SOCIETY JOURNAL (2019)
The Effects of Supplementation with Chromium on Insulin Resistance Indices in Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Javad Heshmati et al.
HORMONE AND METABOLIC RESEARCH (2018)
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
Helena J. Teede et al.
HUMAN REPRODUCTION (2018)
Visit-to-visit variability in blood pressure and Alzheimer's disease
Simona Lattanzi et al.
JOURNAL OF CLINICAL HYPERTENSION (2018)
Metabolic characteristics of normal weight central obesity phenotype polycystic ovary syndrome women: a large-scale national epidemiological survey
Liangshan Mu et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2018)
A Summary on Polycystic Ovary Syndrome: Diagnostic Criteria, Prevalence, Clinical Manifestations, and Management According to the Latest International Guidelines
Adriana Catharina Helena Neven et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2018)
Insulin action and resistance in obesity and type 2 diabetes
Michael P. Czech
NATURE MEDICINE (2017)
Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome
Esmee M. Bordewijk et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Glycosylated Hemoglobin and Functional Outcome after Acute Ischemic Stroke
Simona Lattanzi et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2016)
Glycosylated Hemoglobin and Functional Outcome after Acute Ischemic Stroke
Simona Lattanzi et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2016)
ABNORMAL EXPRESSION OF GENES GOVERNING ADIPOGENESIS AND EXTRACELLULAR MATRIX (ECM) FORMATION IN SUBCUTANEOUS (SC) ABDOMINAL ADIPOSE STEM CELLS (ASCS) OF LEAN POLYCYSTIC OVARY SYNDROME (PCOS) WOMEN
G. D. Chazenbalk et al.
FERTILITY AND STERILITY (2015)
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
Caroline M Apovian et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Testosterone to Dihydrotestosterone Ratio as a New Biomarker for an Adverse Metabolic Phenotype in the Polycystic Ovary Syndrome
J. Muenzker et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
Xiang Wan et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Metformin induces a prompt decrease in LH-stimulated testosterone response in women with PCOS independent of its insulin-sensitizing effects
Dorothea Kurzthaler et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2014)
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
Richard S. Legro et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Effect of Metformin compared with hypocaloric diet on serum C-reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome
Fatemeh Esfahanian et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2013)
Cellular and molecular mechanisms of metformin: an overview
Benoit Viollet et al.
CLINICAL SCIENCE (2012)
Metabolic syndrome in obese men and women with binge eating disorder: developmental trajectories of eating and weight-related behaviors
Kerstin K. Blomquist et al.
COMPREHENSIVE PSYCHIATRY (2012)
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
Evanthia Diamanti-Kandarakis et al.
ENDOCRINE REVIEWS (2012)
Metformin versus lifestyle changes in treating women with polycystic ovary syndrome
Daniella D. G. Curi et al.
GYNECOLOGICAL ENDOCRINOLOGY (2012)
Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis
S. S. Lim et al.
HUMAN REPRODUCTION UPDATE (2012)
Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis
M. Hickey et al.
HUMAN REPRODUCTION (2011)
An assessment of lifestyle modification versus medical treatment with clomiphene citrate, metformin, and clomiphene citrate-metformin in patients with polycystic ovary syndrome
Mohammad Ali Karimzadeh et al.
FERTILITY AND STERILITY (2010)
Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
Carolina Fux Otta et al.
GYNECOLOGICAL ENDOCRINOLOGY (2010)
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
David Moher et al.
INTERNATIONAL JOURNAL OF SURGERY (2010)
Consensus on infertility treatment related to polycystic ovary syndrome
B. C. Tarlatzis et al.
HUMAN REPRODUCTION (2008)
The global challenge of diabetes
[Anonymous]
LANCET (2008)
Metformin versus insulin for the treatment of gestational diabetes
Janet A. Rowan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: A randomized, 12-month, placebo-controlled study
Alessandra Gambineri et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome - a randomised, double-blind, placebo-controlled trial
J. Lord et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2006)
Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study
T Tang et al.
HUMAN REPRODUCTION (2006)
Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents
MO Goodarzi et al.
DIABETES OBESITY & METABOLISM (2005)
Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome
A Gambineri et al.
CLINICAL ENDOCRINOLOGY (2004)
A randomized, 48-week, placebocontrolled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study
KM Hoeger et al.
FERTILITY AND STERILITY (2004)
Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin
CJ Glueck et al.
HUMAN REPRODUCTION (2003)
Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome:: a prospective randomized trial
H Yarali et al.
HUMAN REPRODUCTION (2002)
Share Paper
